Amyl Nitrite
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Amyl Nitrite
- Generic name
- AMYL NITRITE
- Manufacturer
- James Alexander Corporation
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e
- SPL ID
- eb6e373b-5b5d-46ea-90bd-f2dc8d813b13
- Version
- 2
- Effective date
- 2019-02-05
- Source export date
- 2026-10-12
- Source partition
- 11
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:39:13
| Harmonized routes |
|---|
| RESPIRATORY (INHALATION) |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Amyl Nitrite | openfda.brand_name | |
| generic name | AMYL NITRITE | openfda.generic_name | |
| manufacturer name | James Alexander Corporation | openfda.manufacturer_name | |
| ndc | package | 46414-2222-8 | openfda.package_ndc |
| ndc | package | 46414-2222-1 | openfda.package_ndc |
| ndc | product | 46414-2222 | openfda.product_ndc |
| ndc11 | package | 46414222208 | derived:openfda.package_ndc |
| ndc11 | package | 46414222201 | derived:openfda.package_ndc |
| rxcui | 577307 | openfda.rxcui | |
| spl id | eb6e373b-5b5d-46ea-90bd-f2dc8d813b13 | id | |
| spl set id | c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e | set_id | |
| unii | 22T8Z09XAK | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS: Transient episodes of dizziness, weakness, or syncope or other signs of cerebral ischemia due to postural hypotension may develop following inhalation of amyl nitrite, particularly if the patient is standing immobile. To hasten recovery, measures which facilitate venous return such as head low posture, deep breathing and movement of extremities may be used.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: Mild transitory headache, dizziness and flushing of the face are common with the use of amyl nitrite. The following adverse reactions may occur in susceptible patients: syncope, involuntary passing of urine and feces, hypotension, pallor, cold sweat, tachycardia, restlessness, weakness, vomiting and nausea. Excessively high doses of amyl nitrite administered chronically may cause methemoglobinemia.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.